Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30019458HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30019459HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30085139HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023974HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023975HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023976HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS30023977HIVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20042586HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20027367HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TVIS20034731HPVENSG00000162434.14protein_codingJAK1YesYes3716P23458
Q6P669
TCGA Plot Options
Drug Information
GeneJAK1
DrugBank IDDB14845
Drug NameFilgotinib
Target IDBE0004145
UniProt IDP23458
Regulation Typeinhibitor
PubMed IDs31912462
CitationsTarrant JM, Galien R, Li W, Goyal L, Pan Y, Hawtin R, Zhang W, Van der Aa A, Taylor PC: Filgotinib, a JAK1 Inhibitor, Modulates Disease-Related Biomarkers in Rheumatoid Arthritis: Results from Two Randomized, Controlled Phase 2b Trials. Rheumatol Ther. 2020 Mar;7(1):173-190. doi: 10.1007/s40744-019-00192-5. Epub 2020 Jan 7.
GroupsApproved; Investigational
Direct Classification
SMILESO=C(NC1=NN2C(C=CC=C2C2=CC=C(CN3CCS(=O)(=O)CC3)C=C2)=N1)C1CC1
Pathways
PharmGKB
ChEMBLCHEMBL3301607